Search results for "molecular microbiology"
Selected Filters:
binx health submits request for Emergency Use Authorization for first CRISPR-based point-of-care test for COVID-19
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
How FcRn mouse models from JAX reveal antibody half-life and stability
Advancing clinical pharmacokinetic prediction beyond non-human primate models
Unlock the future of PFAS detection with high-resolution mass spectrometry
Discover how Waters' HRMS innovations are enhancing the accuracy and scope of PFAS detection and analysis
Revolutionizing diagnostics with automated, integrated, and standardized clinical mass spectrometry
Guest editorial by Dr. Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems, Senior Vice President, Roche
Partner with bioanalytical MS/MS experts to overcome biomarker assay challenges
Discover how Alturas Analytics offers LC-MS/MS and GC-MS/MS bioanalytical services that support drug developers and enables them to gain a competitive edge in the marketplace
Biomarker Discovery using Surface Plasmon Resonance Imaging
University College London partners with Causaly to accelerate coronavirus research
UCL academics are working with Causaly to help accelerate research into the COVID-19 pandemic, including the identification of biomarkers and potential therapeutic agents
Camena Bioscience uses gSynth to synthesize a 2.7kb plasmid
Enabling new synthetic biology applications including protein production and the engineering of bacteria
Boost sensitivity of metal-sensitive compounds with Restek’s new inert LC columns
New columns are ideal for the analysis of metal-sensitive compounds, including mycotoxins, pesticides, and methylmalonic acid
Uncover the cutting-edge technologies in the field of microscopy
Explore AI-powered image analysis, Raman microscopy and energy-dispersive X-ray spectrometry and how they can be utilized across a range of scientific applications
Abbott’s ID NOW COVID-19 rapid test shows strong agreement to PCR instruments
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
















